Group Leader

    Matej Orešič, Ph.D., Adjunct Professor
    matej.oresic [at]

    LinkedIn, TwitterOrcid
    Google ScholarResearchGateLoop
    Profile at SyMMyS CoE WWW site
    Curriculum Vitae

    Contact Information

    Turku Bioscience
    P.O. Box 123, BioCity
    (Street addr. Tykistökatu 6 B)
    FIN-20521 Turku, Finland
    Phone: +358 44 972 6094
    Email: matej.oresic [at]

    Description of the Research

    Our main research area is systems medicine, particularly metabolomics applications in biomedical research and related integrative bioinformatics. Specifically, we are particularly interested in the identification of disease vulnerabilities associated with different metabolic phenotypes and the underlying mechanisms linking these vulnerabilities with the development of specific disorders or their co-morbidities. Such in-depth understanding of the metabolic phenotypes in health and disease is crucial if one is to implement personalized medicine. Dr. Orešič initiated the popular MZmine open source project, leading to popular software for metabolomics data processing.

    Group Members

    Alex Dickens, D.Phil. – Postdoctoral researcher
    Esko Kemppainen, Ph.D. – Postdoctoral researcher
    Santosh Lamichhane, Ph.D. – Postdoctoral researcher
    Partho Sen, Ph.D. – Postdoctoral researcher
    Andreas Bergmann Dr. rer. hum. – Postdoctoral researcher
    Tuomas Lindeman – Project engineer
    Tuulia Hyötyläinen, Ph.D., Prof. (Örebro University) – Affiliated member
    Aidan McGlinchey, Ph.D., Postdoctoral research associate (Örebro University) – Affiliated member
    (Krista Rantanen, Ph.D. – Project manager -Affiliated member)

    Group members picture

    Main Ongoing Research Projects

    • Strategic Research Agreement, Juvenile Diabetes Research Foundation (9/2016-9/2018): Metabolomic and Proteomic markers staging progression to type 1 diabetes in autoantibody positive children – PI
    • Strategic Research Agreement, Juvenile Diabetes Research Foundation (9/2016-9/2018): Mother-infant interactions in relation to potential biomarkers of beta-cell autoimmunity and type 1 diabetes – PI
    • Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (2012-2017) – PI
    • Strategic Research Agreement, Juvenile Diabetes Research Foundation (Integrative multi-omic study of early progression to type 1 diabetes; 2014-2017) – PI
    • pHealth Programme, multi-PI collaborative project, Academy of Finland (Personalised medicine to predict and prevent Type 1 Diabetes; 9/2015-8/2019) – Co-PI
    • EU H2020 EPoS (Elucidating Pathways of Steatohepatitis) – Workpackage leader
    • EU FP7 METSY (Integrated neuroimaging and metabolic platform for characterisation of early psychosis and prediction of patient outcomes) – Coordinator

    Honors and Awards

    Lifetime Honorary Fellow award to M. Orešič (2016, Metabolomics Society), in recognition of his groundbreaking development of metabolomics data processing tools and powerful analytical methods that have enabled systems-level investigations of processes that lead to obesity and diabetes, with a specific focus on type 1 diabetes.